MADISON, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has authorized
$500 million in share repurchases. The company had approximately 190 million
common shares outstanding as of December 31, 2008.
"This repurchase program demonstrates confidence in our performance and
commitment to increasing shareholder value," said Surya N. Mohapatra, Ph.D.,
Chairman and Chief Executive Officer of Quest Diagnostics.
In 2008, the company repurchased approximately 5.5 million of its common
shares for $254 million, exhausting its prior repurchase authorization.
Quest Diagnostics will hold its fourth quarter conference call on January
26, 2009 at 8:30 A.M. Eastern Time. A simulcast of the call is available by
dialing 415-228-4961, passcode 3214469 and via the Internet at:
www.questdiagnostics.com. Registered analysts may access the call at:
www.streetevents.com. In addition, a replay of the call will be available from
10:30 A.M. on January 26 through midnight on February 23, 2009 to investors in
the U.S. by dialing 866-431-7950. Investors outside the U.S. may dial
203-369-0981. No password is required for either number.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its network of laboratories and patient service
centers, and provides interpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care.
SOURCE Quest Diagnostics
-0- 01/26/2009
/CONTACT: Laure Park, Investors, +1-973-520-2900, or Nancy Fitzsimmons,
Media, +1-973-520-2800, both of Quest Diagnostics /
/Web Site: http://www.questdiagnostics.com /
(DGX)
CO: Quest Diagnostics
ST: New Jersey
IN: MTC
SU: CCA
PR
-- NY62034 --
2034 01/26/200906:55 ESThttp://www.prnewswire.com